There are currently 31 active clinical trials seeking participants for Glaucoma research studies. The states with the highest number of trials for Glaucoma participants are California, Texas, New York and Florida.
Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma
Recruiting
Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment
Gender:
All
Ages:
35 years and above
Trial Updated:
09/26/2023
Locations: Glaukos Investigator Site, Cincinnati, Ohio
Conditions: Glaucoma
Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.
Recruiting
Evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.
Gender:
ALL
Ages:
46 years and above
Trial Updated:
01/02/2025
Locations: Arizona Advanced Eye Research Institute, Glendale, Arizona +36 locations
Conditions: Glaucoma
Comparison of Visual Field Assessments Between Three Perimeters
Recruiting
A single center, prospective, randomized, comparative study of visual field assessments between the TEMPO, VisuALL, and HFA perimeters. Subjects will be assessed at 1 visit. Clinical evaluations will include MD, PSD, FT, VFI, OCT, and a questionnaire.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/04/2024
Locations: North Georgia Eye Associates, Gainesville, Georgia
Conditions: Glaucoma
Electrical Stimulation for the Treatment of Optic Neuropathies
Recruiting
The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/02/2024
Locations: Byers Eye Institute, Palo Alto, California
Conditions: Glaucoma, Glaucoma, Open-Angle, Optic Nerve Diseases
Electrical Stimulation for the Treatment of Glaucoma
Recruiting
The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/02/2024
Locations: Byers Eye Institute, Palo Alto, California +3 locations
Conditions: Glaucoma, Glaucoma, Open-Angle
Tolerability of an Anesthesia-free Tonometer Tip
Recruiting
The purpose of this study is to compare the tolerability and comfort of 3 different prototype anesthesia-free tonometer tips with the standard tonometer tip in conjunction with anesthesia. The best-tolerated prototype anesthesia-free tonometer tip will be identified for further development for home tonometry.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/18/2024
Locations: Duke Eye Center, Durham, North Carolina
Conditions: Glaucoma
Anterior Segment Optical Coherence Tomography Microstent Positioning
Recruiting
The goal of this observational study is to learn about the long-term results of glaucoma stent surgery in men and women 18 or older who have had cataract and microstent surgery in the past 2 years at the Moran Eye Center. The main questions the study aims to answer are: 1. How often are microstents mispositioned? 2. What effect does microstent positioning have on intraocular pressure after surgery? Participants will have a one-time clinic visit for an eye exam and Optical Coherence Tomography... Read More
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
10/29/2024
Locations: Moran Eye Center, Murray, Utah
Conditions: Glaucoma, Stent Migration, Stent Dislodgement, Intraocular Pressure
Topical Insulin for Glaucoma
Recruiting
The purpose of this Phase 1 trial is to determine the safety over 1-2 months of topic sterile human recombinant insulin on subjects with optic neuropathies (glaucoma, ischecmic optic neuropathy, and optic disc drusen).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/28/2024
Locations: Byers Eye Institute at Stanford University, Palo Alto, California
Conditions: Glaucoma
Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance
Recruiting
Glaucoma is a major cause of blindness. The inability to predict a patient's IOP response to medications is a critical barrier for the clinician to consistently provide highly effective IOP-based treatments. Current trial-and-error approaches to glaucoma management are inefficient and have not addressed this barrier as there are no predictive factors for drug response. Our long-term goal is to improve outcomes by identifying biomarkers and environmental factors that profile a patient at risk for... Read More
Gender:
ALL
Ages:
30 years and above
Trial Updated:
10/25/2024
Locations: Mayo Clinic, Rochester, Minnesota +2 locations
Conditions: Glaucoma, OHT - Ocular Hypertension
Optimize Pediatric OCT Imaging
Recruiting
Handheld optical coherence tomography (OCT) has become an important imaging modality to evaluate the pediatric retina. The objective of this pilot study is to compare a new contact OCT system (Theia Imaging) with an investigational noncontact OCT system (Duke Biomedical Engineering) to assess their ability to image the pediatric retina. The investigators hypothesize that the contact OCT system is superior in imaging larger areas of the retina (larger field-of-view), while it has similar resolut... Read More
Gender:
ALL
Ages:
All
Trial Updated:
10/08/2024
Locations: Duke University Eye Center, Durham, North Carolina
Conditions: Retinal Disease, Glaucoma, Optic Nerve Diseases
Hyperbaric Oxygen Therapy for Optic Neuropathies
Recruiting
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/24/2024
Locations: Byers Eye Institute, Palo Alto, California
Conditions: Optic Neuropathy, Glaucoma
Glaucoma Evaluation With the P200TE
Recruiting
Images captured on the P200TE device on glaucoma patients
Gender:
ALL
Ages:
22 years and above
Trial Updated:
09/05/2024
Locations: Werner Optometry, Cajon, California +1 locations
Conditions: Glaucoma